On April 1, 2026, BiomX Inc. announced that it has entered into an Option and Undertaking Agreement with Mandragola Ltd., granting BiomX an exclusive option to purchase 100% of Mandragola's shareholdings in DR. Frucht Systems Ltd. (DFSL), an Israeli company specializing in advanced detection systems for security and defense applications. The agreement is contingent upon Mandragola's successful acquisition of 60% of DFSL's issued share capital, which is subject to standard closing conditions and the approval of the Israel Innovation Authority. The purchase price for the option includes a cash payment of $100,000, a $5 million unsecured convertible promissory note, and additional equity considerations in the form of preferred stock and warrants. This strategic move positions BiomX to enhance its operational capabilities in the defense sector, particularly in anti-drone technology, which is increasingly critical in today's security landscape. The acquisition is expected to significantly bolster BiomX's market presence and operational execution in the technology sector, aligning with its long-term strategy to expand its portfolio and enhance shareholder value.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.